METHOD FOR CONTROLLING NAD(P)/NAD(P)H RATIO BY OXIDOREDUCTASE
    1.
    发明申请
    METHOD FOR CONTROLLING NAD(P)/NAD(P)H RATIO BY OXIDOREDUCTASE 审中-公开
    通过氧化还原酶控制NAD(P)/ NAD(P)H比例的方法

    公开(公告)号:US20140106387A1

    公开(公告)日:2014-04-17

    申请号:US14135015

    申请日:2013-12-19

    Abstract: Provided is a method capable of effectively treating various diseases associated with energy excess, such as obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, via elevation of an NAD(P)+/NAD(P)H ratio by increasing an NAD(P)+ concentration in vivo or in vitro through use of NAD(P)H as a substrate or coenzyme by oxidoreductase such as NAD(P)H:quinone oxidoreductase (NQO1), a method of screening a drug for the same and a therapeutic drug.

    Abstract translation: 本发明提供能够通过NAD(P)+ / NAD(P)H比例升高来有效治疗与能量过量相关的各种疾病,如肥胖,糖尿病,代谢综合征,退行性疾病和线粒体功能障碍相关疾病的方法。 通过使用NAD(P)H作为底物或通过氧化还原酶如NAD(P)H:醌氧化还原酶(NQO1)的氧化还原酶的辅酶,在体内或体外增加NAD(P)+浓度, 相同和治疗药物。

    METHOD FOR CONTROLLING NAD(P)/NAD(P)H RATIO BY OXIDOREDUCTASE
    10.
    发明申请
    METHOD FOR CONTROLLING NAD(P)/NAD(P)H RATIO BY OXIDOREDUCTASE 审中-公开
    通过氧化还原酶控制NAD(P)/ NAD(P)H比例的方法

    公开(公告)号:US20090215145A1

    公开(公告)日:2009-08-27

    申请号:US12162293

    申请日:2007-02-15

    Abstract: Provided is a method capable of effectively treating various diseases associated with energy excess, such as obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, via elevation of an NAD(P)+/NAD(P)H ratio by increasing an NAD(P)+ concentration in vivo or in vitro through use of NAD(P)H as a substrate or coenzyme by oxidoreductase such as NAD(P)H:quinone oxidoreductase (NQO1), a method of screening a drug for the same and a therapeutic drug.

    Abstract translation: 本发明提供能够通过NAD(P)+ / NAD(P)H比例升高来有效治疗与能量过量相关的各种疾病,如肥胖,糖尿病,代谢综合征,退行性疾病和线粒体功能障碍相关疾病的方法。 通过使用NAD(P)H作为底物或通过氧化还原酶如NAD(P)H:醌氧化还原酶(NQO1)的氧化还原酶的辅酶,在体内或体外增加NAD(P)+浓度, 相同和治疗药物。

Patent Agency Ranking